RNTX
Rein Therapeutics Inc. · Healthcare
Voss Capital, LP bought $423K of Rein Therapeutics Inc.
10% owner
Bought$423,466
$1.38Price
306,050Shares
+30%Stake
What RNTX did for a copier
- $1,000 copied at Wed, Oct 29 open, $1.42
- $1,085
- S&P 500, same days
- +0.1%
Measured over 30 trading days, to the Dec 11 close.
Voss Capital, LP's record
6 other buys with 3 months of prices since 2020: on average −20.6% against the S&P 500, and 1 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Oct 24. Filed Tue, Oct 28, 6:45 PM ET, after the close. Returns use the Oct 29 open and the Dec 11 close. Not investment advice.